The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Zhang, Qi ^a   Zheng, Huizhen ^b   Liu, Meizhen ^b   Han, Ke ^b   Shu, Jun ^b   Wu, Chenggang ^b   Xu, Ning ^b   He, Qiushui ^c   Luo, Huiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Anti PT IgG; China; Cross sectional study; Pertussis; Sero epidemiology

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFANT; INFECTION RATE; MALE; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTITOXINS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PERTUSSIS TOXIN; SEROEPIDEMIOLOGIC STUDIES; WHOOPING COUGH; YOUNG ADULT;

EID: 84862321563     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-138     Document Type: Article

References (32)

1. TE Tan T, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005, 24:S10-S18. 10.1097/01.inf.0000160708.43944.99, 15876918.
2. Forsyth K, Tan T, von Konig CH. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 2005, 24:S69-S74. 10.1097/01.inf.0000160917.29723.03, 15876930.
3. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18:326-382. 10.1128/CMR.18.2.326-382.2005, 1082800, 15831828.
4. WHO Immunization Profile - China 2010, , , WHO.
5. Jian F, Yue-fang W, Bao-xiang X. Analysis on Pertussis Epidemiology in Zhejiang Province in 1954-2004. Chin J Vaccines and Immunization 2005, 11(4):279-281.
6. Yan Y, Lin-qi D, Zhen-yuan S. Analysis on Epidemiology in 1963-2002 and Control Strategy on Pertussis in Henan Province. Chin J Vaccines and Immunization 2005, 11:402-404.
7. China Information System for Diseases Control and Prevention http://10.249.1.170.
8. China Ministry of Health Chinese Health Statistical Digest 2010, 47-48. China Ministry of Health.
9. Meng CY, Zhang WH. Current Status and Perspective of Worldwide Disease Burden of Pertussis. Chin J Vaccines and Immunization 2006, 12:318-321.
10. Muller FM, Hoppe JE. Wirsing von Konig CH: Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997, 35:2435-2443. 229988, 9316885.
11. Hodder SL, Cherry JD, Mortimer EA. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 2000, 31(1):7-14. 10.1086/313913, 10913389.
12. Liao AS, Zhong XZ. Investigation on the level of antibodies against pertussis in children in Shantou City. Int J Lab Med 2006, 7:605-608.
13. Yi Y, Dai CW. Surveillance on Antibody Levels of Pertussis, Diphtheria and Tetanus in Healthy Poputation of Nanshan District, Shenzhen City. Practical Preventive Med 2007, 5:1437-1438.
14. Chen W, Jing LY, Gao ZG. Analysis on monitoring for antibody level of pertussis and diphtheria among people aged 2 to 17 years in Tianjin City in 2004. Disease Surveillance 2006, 3:123-124.
15. Liu MZ, He CW. Results of monitoring of antibody levels of pertussis, dipheria and tetanusin healthy population in Guangdong Province. China Tropical Med 2008, 4:625-627.
16. Xu L, Lu J. Serological surveillance on antibody levels to pertussis, diphtheria and tetanus among healthy people aged<30 years in Nanjing. Dis Surveillance 2010, 12:958-961.
17. de Melker HE, Versteegh FG, Schellekens JF. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006, 53:106-113. 10.1016/j.jinf.2005.10.020, 16352342.
18. Riffelmann M, Thiel K, Schmetz J. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010, 48:4459-4463. 10.1128/JCM.01371-10, 3008456, 20943873.
19. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38:800-806. 86208, 10655388.
20. Gordon M, Davies HD, Gold R. Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. Pediatr Infect Dis J 1994, 13:617-622. 10.1097/00006454-199407000-00007, 7970950.
21. Zhang Q, Han F, Nie Q. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect 2011, 63:441-446. 10.1016/j.jinf.2011.07.018, 21864569.
22. Pertussis vaccination overview in European countries http://www.euvac.net/graphics/euvac/vaccination/pertussis.
23. Pertussis (Whooping Cough) Vaccination http://www.cdc.gov/vaccines/vpd-vac/pertussis/default.
24. Yih WK, Lett SM, des Vignes FN. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000, 182:1409-1416. 10.1086/315863, 11023464.
25. von Konig CH W, Gounis D, Laukamp S. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis 1999, 18:341-345. 10.1007/PL00015016, 10421041.
26. Pebody RG, Gay NJ, Giammanco A. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005, 133:159-171. 10.1017/S0950268804003012, 2870234, 15724723.
27. Cattaneo LA, Reed GW, Haase DH. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996, 173:1256-1259. 10.1093/infdis/173.5.1256, 8627081.
28. Campins-Marti M, Cheng HK, Forsyth K. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001, 20:641-646. 10.1016/S0264-410X(01)00393-0, 11738728.
29. Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010, 7:e1000291. 10.1371/journal.pmed.1000291, 2889930, 20585374.
30. Rendi-Wagner P, Tobias J, Moerman L. The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection. Vaccine 2010, 28:3285-3290. 10.1016/j.vaccine.2010.02.104, 20226250.
31. von Konig CH W, Postels-Multani S, Bock HL. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995, 346:1326-1329. 10.1016/S0140-6736(95)92343-8, 7475771.
32. He Q, Viljanen MK, Olander RM. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J Infect Dis 1994, 170:705-708. 10.1093/infdis/170.3.705, 8077734.